Inventaire - your friends and communities are your best library

Implementing personalized cancer genomics in clinical trials

published in: Nature Reviews Drug Discovery

date of publication: 2013-05-01

main subject: genomics

Cites articles 76

Date

Title

Authors

2013-02-14

SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data

Jun Wang, Wenlong Jia, Shaoliang Peng
2013-02-10

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

Carrie Sougnez, Kristian Cibulskis, Gad Getz, Stacey Gabriel, Eric Lander, Matthew Meyerson, Andrey Sivachenko
2012-07-04

Cancer of the ampulla of Vater: analysis of the whole genome sequence exposes a potential therapeutic vulnerability

Jeffrey Trent
2012-02-12

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

Pasi A Jänne
2012-11-01

Assuring the quality of next-generation sequencing in clinical laboratory practice

Justin M Zook, Birgitte B Simen, David Dimmock, Heidi L. Rehm, Andrew Kasarskis, Teri Manolio, Elaine Mardis
2012-12-27

Combining highly multiplexed PCR with semiconductor-based sequencing for rapid cancer genotyping
2012-03

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

Elaine Mardis
2012-01-26

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

Federica Di Nicolantonio, Alberto Bardelli, Chong Sun, René Bernards, Davide Zecchin
2012-03-29

Report on emerging technologies for translational bioinformatics: a symposium on gene expression profiling for archival tissues

Levi Waldron, Curtis Huttenhower, Peter T. Simpson
2012-03-08

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Aron Charles Eklund, Gordon Stamp, Stuart Horswell, Bradley Spencer-Dene, Charles Swanton, Sharmin Begum, Julian Downward, Keiran Raine, Pierre Martinez, Marco Gerlinger, Zoltan Szallasi, Eva Gronroos, P. Andrew Futreal, Ignacio Varela, Calli Latimer, David R. Jones, Andrew Rowan, Benjamin Phillimore, Lisa Pickering, Patrick S. Tarpey, Aengus Stewart, David Endesfelder, Nicholas E Matthews
2012-10-01

Intratumor heterogeneity: evolution through space and time

Charles Swanton
2012-12-18

Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents

Gideon Bollag, Garth Powis, Ignacio I Wistuba, Gordon B. Mills
2012-03-02

Combinations of BRAF, MEK, and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations
2012-11

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

Igor Puzanov, Adil Daud, Georgina V. Long, Richard F. Kefford, Keith Flaherty, Jeffrey S Weber, Jeffrey A Sosman, Nageatte Ibrahim, Peter F Lebowitz, Omid Hamid, Lynn Schuchter, Jonathan Cebon, Ragini R Kudchadkar, Howard A Burris, Gerald Falchook, Alain P Algazi, Shonda Little, Daniele Ouellet, Kiran D Patel
2012-01-11

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
2012-07-20

The origin and evolution of mutations in acute myeloid leukemia
2012-11-17

Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial

Olivier Trédan, Nicolas Servant, Marc-Henri Stern, Anne-Gaëlle Le Coroller, Anne Vincent-Salomon
2012-10-01

A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.

Oliver P Gautschi
2012-05-01

BRAF inhibition in refractory hairy-cell leukemia.

Christof von Kalle, Thorsten Zenz
2012-02-01

Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics
2012-06-20

Sequence analysis of mutations and translocations across breast cancer subtypes

Carrie Sougnez, Kristian Cibulskis, Gad Getz, Daniel Auclair, Eric Lander, Melissa Parkin, Josep Baselga, Juan Carlos Fernandez-Lopez, Sandra Romero-Cordoba, Kristin Brown, Alfredo Hidalgo-Miranda, Matthew Meyerson, Stacey Gabriel, Levi A Garraway, Todd Golub, Rameen Beroukhim, Kornelia Polyak
2012-01-24

Targeting MET in cancer: rationale and progress

Carmen Birchmeier
2012-03-10

ROS1 rearrangements define a unique molecular class of lung cancers

Mari Mino-Kenudson, Sai-Hong Ignatius Ou, William Pao, Christine M. Lovly, Nerina T McDonald, Jeffrey A Engelman, A John Iafrate, Kristin Bergethon, Keith D Wilner, Eunice L Kwak, Jeffrey W Clark, Alice T Shaw
2012

Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma
2012-03-01

New dream team for melanoma therapy
2011-02-01

A decade's perspective on DNA sequencing technology

Elaine Mardis
2011-11-07

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing

Brendan Blumenstiel, Matthew DeFelice, Matthew Meyerson, Stacey Gabriel, Levi A Garraway, William C Hahn
2011-08-09

Exome sequencing-based copy-number variation and loss of heterozygosity detection: ExomeCNV

John Quackenbush, Stanley F Nelson
2011-08-18

Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data

Jay Shendure
2011-01

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

P. Andrew Futreal, Andrew Menzies, Jon Teague, Michael Stratton
2011-09-29

Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity

Hans Lehrach, Martin Kerick, Ralf Herwig, Holger Sültmann
2011-08-02

The ethical use of mandatory research biopsies

Eric Winer, Nancy U Lin, Ian E Krop

Article - wd:Q38102920

Welcome to Inventaire

the library of your friends and communities

learn more